文献速递甲状腺疾病性腺与生殖内分泌

妊娠期母体甲状腺功能与产科及围产期结局的关联

Associations Between Maternal Thyroid Function in Pregnancy and Obstetric and Perinatal Outcomes.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该回顾性队列研究纳入2003至2014年在波士顿医疗中心产检的8413例孕产妇及其胎儿和婴儿,评估妊娠期促甲状腺激素水平与产科及围产期结局的关联。结果显示,母体TSH>4 mIU/L与早产(RR 2.17)和新生儿呼吸窘迫综合征(RR 2.83)风险增加相关,但与胎儿丢失、子痫前期/子痫及低出生体重的风险增加无统计学显著性。

要点

  • 8413例孕产妇中130例(1.6%)TSH>4 mIU/L,中位TSH为1.06 mIU/L。
  • TSH>4 mIU/L者早产风险RR 2.17(95%CI 1.15-4.07,P=.016)。
  • TSH>4 mIU/L者新生儿呼吸窘迫综合征风险RR 2.83(95%CI 1.02-7.86,P=.046)。

核心结论

  • 妊娠期母体血清TSH浓度>4 mIU/L与子代早产及新生儿呼吸窘迫综合征风险约2倍增加相关。
  • TSH升高还与胎儿丢失、子痫前期/子痫及低出生体重的风险增加相关,但无统计学显著性。

研究设计与样本

  • 回顾性队列研究,纳入2003年1月1日至2014年5月22日在波士顿医疗中心接受产前保健的年龄≥18岁、单胎妊娠且无已知甲状腺疾病的女性及其胎儿和婴儿。
  • 共纳入8413例孕产妇(平均年龄29.1岁,15%白人,60%黑人,13%西班牙裔)及其胎儿和婴儿(平均出生孕周38.5周,52%男性,平均出生体重3.2 kg)。

主要发现

  • TSH中位数(四分位距)为1.06(0.62-1.60)mIU/L,130例女性(1.6%)TSH>4 mIU/L。
  • 与TSH≤4 mIU/L相比,TSH>4 mIU/L与早产风险增加相关(RR 2.17,95%CI 1.15-4.07,P=.016)。
  • 与TSH≤4 mIU/L相比,TSH>4 mIU/L与新生儿呼吸窘迫综合征风险增加相关(RR 2.83,95%CI 1.02-7.86,P=.046)。
  • TSH>4 mIU/L与胎儿丢失、子痫前期/子痫及低出生体重的风险比增加相关,但无统计学显著性。
  • TSH>4 mIU/L与早产临产、胎盘早剥、剖宫产、妊娠期高血压或糖尿病、新生儿重症监护病房入院无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The effects of maternal subclinical hypothyroidism on pregnancy outcomes are not clear. OBJECTIVE: We aimed to assess potential associations between maternal thyrotropin (thyroid-stimulating hormone [TSH]) levels in pregnancy and obstetric and perinatal outcomes. DESIGN: Retrospective cohort study. SETTING: Tertiary academic medical center. PATIENTS: Women aged ≥18 years with a singleton gestation and no known thyroid disease seen for prenatal care at Boston Medical Center from January 1, 2003 through May 22, 2014, and their fetuses and infants were included. MAIN OUTCOME MEASURES: Risk ratios of adverse obstetric and perinatal outcomes. RESULTS: A total of 8,413 pregnant women (mean age 29.1 years, 15% white, 60% black, 13% Hispanic) and their fetuses and infants (mean gestational age at birth 38.5 weeks, 52% male, mean birth weight 3.2 kg) were included in the analyses. The median (interquartile range) TSH level was 1.06(0.62-1.60) mIU/L, and 130 women (1.6%) had TSH > 4 mIU/L. Maternal TSH levels > 4 mIU/L were associated with increased risks of prematurity (risk ratio [RR] 2.17 [95% confidence interval 1.15-4.07] P = .016) and neonatal respiratory distress syndrome (RDS) (RR 2.83 [95% confidence interval 1.02-7.86] P = .046) compared to TSH levels ≤ 4 mIU/L. Although not statistically significant, TSH levels > 4 mIU/L were also associated with increased RRs for fetal loss, preeclampsia/eclampsia, and low birth weight. TSH levels > 4 mIU/L were not associated with preterm labor, placental abruption, cesarean section, gestational hypertension or diabetes, or neonatal intensive care unit admission. CONCLUSION: Maternal serum TSH concentration > 4 mIU/L in pregnancy was associated with approximately 2-fold increased risks of prematurity and RDS in offspring. Elevated TSH was also associated with statistically non-significant increases in the risk of fetal loss, preeclampsia/eclampsia, and low birth weight.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lee SY, Cabral HJ, Aschengrau A, et al. Associations Between Maternal Thyroid Function in Pregnancy and Obstetric and Perinatal Outcomes. J Clin Endocrinol Metab. 2020. PMID: 31838502. doi:10.1210/clinem/dgz275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。